A Single Arm Pilot Study of Intrathecally Administered DepoCyt With Systemic Sorafenib in the Treatment of Neoplastic Meningitis From Solid Tumors.
Phase of Trial: Phase II
Latest Information Update: 27 Mar 2012
At a glance
- Drugs Cytarabine; Sorafenib
- Indications Neoplastic meningitis
- Focus Adverse reactions
- 09 Aug 2011 Planned end date changed from 1 Sep 2016 to 1 Feb 2011 as reported by ClinicalTrials.gov.
- 09 Aug 2011 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
- 18 Feb 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.